SCHEMBL14255203

SCHEMBL14255203

COC(=O)c1cc2cc(Br)cnc2c(=O)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ CHEK1 O14757 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ RAB9A P51151 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ PLIN1 O60240 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ PLIN5 Q00G26 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ ABHD5 Q8WTS1 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ BRD4 O60885 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14255204 0.86 KDM4E (0.47) KDM4ECHEK1ALDH1A1HPGDNPSR1
SCHEMBL14255198 0.86 KDM4E (0.45) KDM4EALDH1A1HPGDNPSR1MAPK1
SCHEMBL14255509 0.86 CHEK1 (0.47) KDM4ECHEK1L3MBTL1RAB9ANPC1
SCHEMBL14255194 0.81 ALDH1A1 (0.42) KDM4EALDH1A1HPGDNPSR1LMNA
SCHEMBL14255189 0.81 KDM4E (0.53) KDM4EALDH1A1HPGDNPSR1RAB9A
SCHEMBL9125289 0.76 PSMD14 (0.50) KDM4EALDH1A1MAPK1RAB9ALMNA
SCHEMBL14255197 0.75 KDM4E (0.48) KDM4EALDH1A1HPGDNPSR1MAPK1
SCHEMBL14255187 0.73 KDM4E (0.57) KDM4EALDH1A1HPGDNPSR1RAB9A
SCHEMBL14255508 0.72 ABL1 (0.49) KDM4ECHEK1ALDH1A1HPGDL3MBTL1
SCHEMBL1071827 0.72 ALDH1A1 (0.56) KDM4EALDH1A1HPGDNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
EP-1313725-B1 TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORP (US) 2007-04-11 — — EP disclosed
Send feedback